FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NYSE:HCC

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://crwefinance.com/21307/stock-alerts/vtus-crwe-hcc-dfg-dow-stock-ma...

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

HCC Insurance Holdings Inc. (NYSE:HCC) announced that Chief Executive Officer John N. Molbeck, Jr. and President Christopher J.B. Williams will be presenting at the Keefe, Bruyette & Woods 2011 Insurance Conference in New York, New York on Thursday, September 8, 2011, beginning at 2:05 p.m. Eastern Daylight Time.

HCC Insurance Holdings Inc. (NYSE:HCC) announced that Chief Executive Officer John N. Molbeck, Jr. and President Christopher J.B. Williams will be presenting at the Keefe, Bruyette & Woods 2011 Insurance Conference in New York, New York on Thursday, September 8, 2011, beginning at 2:05 p.m. Eastern Daylight Time.

CIT Group, Inc. (NYSE:CIT) reported net income for the quarter ended December 31, 2010 of $75 million, $0.37 per diluted share. Net income for the full year was $517 million, $2.58 per diluted share. “I am pleased with the significant progress we have made this past year,” said John A. Thain, Chairman and Chief Executive Officer.

MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, announced Bodybuilding.com selected the Company as the Supplement Company of the Month for October.

ADVERTISE WITH US